Paper68783
Radioimmunoassay of bleomycin in plasma and urine.
Teale JD and 2 others. Br J Cancer, 1977. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Radioimmunoassay of bleomycin in plasma and urine. Papers, record 68783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68783
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Radioimmunoassay | Major topic |
| Animals | |
| Antibody Specificity | |
| Cross Reactions | |
| Hot Temperature | |
| Humans | |
| Rabbits |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 239149 | The development of a radioimmunoassay for cannabinoids in blood and urine. | J Pharm Pharmacol | 1975 | https://conductscience.org/library/papers/239149 | PubMed |
| 2 | 4131806 | Studies on bleomycin: chemistry and the biological action. | Biomedicine | 1973 | https://conductscience.org/library/papers/4131806 | PubMed |
| 3 | 4132697 | Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. | Cancer | 1974 | https://conductscience.org/library/papers/4132697 | PubMed |
| 4 | 558786 | Radioimmunoassay of vinblastine and vincristine. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/558786 | PubMed |
| 5 | 58723 | Synthesis and the lethality of bleomycin in bacteria. | Cancer Res | 1976 | https://conductscience.org/library/papers/58723 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35799941 | Target-induced activation of DNAzyme for highly sensitive colorimetric detection of bleomycin via DNA scission. | RSC Adv | 2022 | https://conductscience.org/library/papers/35799941 | PubMed |
| 30083864 | Molecular beacon-templated silver nanoclusters as a fluorescent probe for determination of bleomycin via DNA scission. | Mikrochim Acta | 2018 | https://conductscience.org/library/papers/30083864 | PubMed |
| 22932298 | New Delhi metallo-β-lactamase 4-producing Escherichia coli in Cameroon. | Emerg Infect Dis | 2012 | https://conductscience.org/library/papers/22932298 | PubMed |
| 7201846 | Enhancement of human chorionic gonadotrophin production by antimetabolites. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7201846 | PubMed |
| 6203661 | Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6203661 | PubMed |
| 2421936 | Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/2421936 | PubMed |
| 574019 | A radioimmunoassay for cytosine arabinoside. | Br J Cancer | 1979 | https://conductscience.org/library/papers/574019 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68783
GET https://conductscience.org/api/papers/v1/68783/authors